International Perspective of Mohs Micrographic Surgery: Australia and New Zealand

  • Greg Julian Goodman
  • Vanessa A. Morgan
  • Tim J. Rutherford
  • Edward J. Upjohn
  • Paul J. M. Salmon
Chapter

Abstract

Mohs micrographic surgery (MMS) in Australia and New Zealand is of utmost importance given their extreme prevalence and incidence figures for skin cancer.

MMS is a rapidly growing subspecialty in Australia with surgeons exhibiting variable activity with the average number of cases per year being 201–300 of which 98% of tumors treated are located on head, neck, digits, or genitals.

The Mohs national database was established in 1993 to log the total number of cases performed in Australia and collected data on over 12,000 cases of Mohs surgery between 1993 and 1999.

Five-year follow-up studies have shown that 5-year recurrence rates for BCCs were 1.4% for primary and 4% for recurrent tumors. For SCCs, 5-year recurrence rates were 3.9% overall and 8% in those with perineural invasion. Perineural invasion was seen in 2.74% of BCCs and 5.95% of SCCs.

Mohs micrographic surgery and secondary intention wound healing of the nail apparatus for in situ and invasive SCC produce excellent wound healing and cure rate with retention of function.

New Zealand also has a very high rate of skin cancer, and MMS in New Zealand needs to be seen in the context of individuals with widespread sun-damaged skin. Multiple facial tumors in a patient are very common. A dysplastic field also influences repair options.

Keywords

Micrographic surgery Nails Australian Mohs database 

References

  1. 1.
    Marks R, Ponsford MW, Selwood TS, Goodman G, Mason G. Non-melanotic skin cancer and solar keratoses in Victoria. Med J Aust. 1983;2(12):619–22.PubMedGoogle Scholar
  2. 2.
    Marks R, Foley P, Goodman G, Hage BH, Selwood TS. Spontaneous remission of solar keratoses: the case for conservative management. Br J Dermatol. 1986;115(6):649–55.PubMedCrossRefGoogle Scholar
  3. 3.
    Leibovitch I, Huilgol SC, Richards S, Paver R, Selva D. Scalp tumors treated with Mohs micrographic surgery: clinical features and surgical outcome. Dermatol Surg. 2006;32(11):1369–74.PubMedCrossRefGoogle Scholar
  4. 4.
    Leibovitch I, Huilgol SC, Selva D, Paver R, Richards S. Cutaneous lip tumours treated with Mohs micrographic surgery: clinical features and surgical outcome. Br J Dermatol. 2005;153(6):1147–52.PubMedCrossRefGoogle Scholar
  5. 5.
    Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up. J Am Acad Dermatol. 2005;53(3):452–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years. J Am Acad Dermatol. 2005;53(3):445–51.PubMedCrossRefGoogle Scholar
  7. 7.
    Leibovitch I, Huilgol SC, Selva D, Hill D, Richards S, Paver R. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years. J Am Acad Dermatol. 2005;53(2):253–60.PubMedCrossRefGoogle Scholar
  8. 8.
    Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R. Basosquamous carcinoma: treatment with Mohs micrographic surgery. Cancer. 2005;104(1):170–5.PubMedCrossRefGoogle Scholar
  9. 9.
    Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R. Cutaneous squamous carcinoma in situ (Bowen’s disease): treatment with Mohs micrographic surgery. J Am Acad Dermatol. 2005;52(6):997–1002.PubMedCrossRefGoogle Scholar
  10. 10.
    Leibovitch I, Huilgol SC, Selva D, Lun K, Richards S, Paver R. Microcystic adnexal carcinoma: treatment with Mohs micrographic surgery. J Am Acad Dermatol. 2005;52(2):295–300.PubMedCrossRefGoogle Scholar
  11. 11.
    Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R. Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion. J Am Acad Dermatol. 2005;53(3):458–63.PubMedCrossRefGoogle Scholar
  12. 12.
    Leibovitch I, Huilgol SC, Selva D, Hill D, Richards S, Paver R. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia II. Perineural invasion. J Am Acad Dermatol. 2005;53(2):261–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Malhotra R, James CL, Selva D, Huynh N, Huilgol SC. The Australian Mohs database: periocular squamous intraepidermal carcinoma. Ophthalmology. 2004;111(10):1925–9.PubMedGoogle Scholar
  14. 14.
    Leibovitch I, Huilgol SC, Hsuan JD, Selva D. Incidence of host site complications in periocular full thickness skin grafts. Br J Ophthalmol. 2005;89(2):219–22.PubMedCrossRefGoogle Scholar
  15. 15.
    Leibovitch I, Huilgol SC, Richards S, Paver R, Selva D. Periocular microcystic adnexal carcinoma: management and outcome with Mohs’ micrographic surgery. Ophthalmologica. 2006;220(2):109–13.PubMedCrossRefGoogle Scholar
  16. 16.
    Malhotra R, Huilgol SC, Huynh NT, Selva D. The Australian Mohs database: periocular squamous cell carcinoma. Ophthalmology. 2004;111(4):617–23.PubMedCrossRefGoogle Scholar
  17. 17.
    Malhotra R, Huilgol SC, Huynh NT, Selva D. The Australian Mohs database, part I: periocular basal cell carcinoma experience over 7 years. Ophthalmology. 2004;111(4):624–30.PubMedCrossRefGoogle Scholar
  18. 18.
    Malhotra R, Huilgol SC, Huynh NT, Selva D. The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up. Ophthalmology. 2004;111(4):631–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Huilgol SC, Selva D, Chen C, Hill DC, James CL, Gramp A, et al. Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision. Arch Dermatol. 2004;140(9):1087–92.PubMedCrossRefGoogle Scholar
  20. 20.
    Kumar B, Roden D, Vinciullo C, Elliott T. A review of 24 cases of Mohs surgery and ophthalmic plastic reconstruction. Aust N Z J Ophthalmol. 1997;25(4):289–93.PubMedCrossRefGoogle Scholar
  21. 21.
    Limawararut V, Leibovitch I, Sullivan T, Selva D. Periocular squamous cell carcinoma. Clin Experiment Ophthalmol. 2007;35(2):174–85.PubMedCrossRefGoogle Scholar
  22. 22.
    Chan FM, O’Donnell BA, Whitehead K, Ryman W, Sullivan TJ. Treatment and outcomes of malignant melanoma of the eyelid: a review of 29 cases in Australia. Ophthalmology. 2007;114(1):187–92. Epub November 30, 2006.PubMedCrossRefGoogle Scholar
  23. 23.
    Ooi CG, James CL, Huilgol SC. Metastatic Bowen carcinoma. Australas J Dermatol. 2006;47(4):277–80.PubMedCrossRefGoogle Scholar
  24. 24.
    Leibovitch I, Selva D, Huilgol S, Davis G, Dodd T, James CL. Intraepithelial sebaceous carcinoma of the eyelid misdiagnosed as Bowen’s disease. J Cutan Pathol. 2006;33(4):303–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Ly H, Selva D, James CL, Huilgol SC. Superficial malignant fibrous histiocytoma presenting as recurrent atypical fibroxanthoma. Australas J Dermatol. 2004;45(2):106–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Lai TF, Huilgol SC, Selva D, James CL. Eyelid sebaceous carcinoma masquerading as in situ squamous cell carcinoma. Dermatol Surg. 2004;30(2 Pt 1):222–5.PubMedCrossRefGoogle Scholar
  27. 27.
    Kearney C, Sheridan A, Vinciullo C, Elliott T. A tunneled and turned-over nasolabial flap for reconstruction of full thickness nasal ala defects. Dermatol Surg. 2010;36(8):1319–24. Epub June 24, 2010.PubMedCrossRefGoogle Scholar
  28. 28.
    Salmon P, Stanway A. Nasalis flap and graft repair provides reliable closure for denuded defects of the nose. Dermatol Surg. 2005;31(6):692–6.PubMedCrossRefGoogle Scholar
  29. 29.
    Smith H, Elliot T, Vinciullo C. Repair of nasal tip and alar defects using cheek-based 2-stage flaps: an alternative to the median forehead flap. Arch Dermatol. 2003;139(8):1033–6.PubMedCrossRefGoogle Scholar
  30. 30.
    Salmon PJ, Mortimer NJ, Hill SE. Muscular hinge flaps: utility and technique in facial reconstructive surgery. Dermatol Surg. 2010;36(2):227–34.PubMedCrossRefGoogle Scholar
  31. 31.
    Tan E, Mortimer NJ, Hussain W, Salmon PJ. The nasal sidewall rotation flap: a workhorse flap for small defects of the distal nose. Dermatol Surg. 2010;36(10):1563–7.PubMedCrossRefGoogle Scholar
  32. 32.
    Lim P, Paver R, Peñas PF. Mohs micrographic surgery at the Skin and Cancer Foundation Australia, 10 years later (1997 vs. 2007). J Am Acad Dermatol. 2010;63(5):832–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Campbell RM, Perlis CS, Mohsin K, et al. Characteristics of Mohs practices in the United States: a recall survey of ACMS surgeons. Dermatol Surg. 2007;33:1413–8.PubMedGoogle Scholar
  34. 34.
    Goodman GJ, Tuxen AJ. Mohs micrographic surgery and subsequent secondary intention wound healing for squamous cell carcinoma and Bowen’s disease of the nail unit. In preparation.Google Scholar
  35. 35.
    Salmon PJM et al. Extremely high levels of melanoma in Tauranga, New Zealand: possible causes and comparisons with Australia and the northern hemisphere. Australas J Dermatol. 2007;48(4):208–16.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2012

Authors and Affiliations

  • Greg Julian Goodman
    • 1
  • Vanessa A. Morgan
    • 2
  • Tim J. Rutherford
    • 3
  • Edward J. Upjohn
    • 2
  • Paul J. M. Salmon
    • 4
  1. 1.Dermatology Institute of VictoriaSouth YarraAustralia
  2. 2.Skin and Cancer FoundationCarltonAustralia
  3. 3.Victorian Dermatology & SurgeryMalnernAustralia
  4. 4.Dermatologic SurgerySkin Cancer InstituteTauranga Bay of PlentyNew Zealand

Personalised recommendations